Please login to the form below

Data by

22

Revenue 2014

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Novartis' Rydapt approval ends long AML therapy drought

Daiichi Sankyo's quizartinib - acquired along with Ambit Biosciences' for $410m in 2014 - and Arog Pharma's crenolanib are both in phase III testing in FLT3-positive AML.

Japanese pharma pulls no punches with post-Brexit UK

The level of investment on the pharmaceutical side is considerable. The Japanese Pharmaceutical Group (JPG), an association of nine drugmakers - Astellas, Chugai, Daiichi-Sankyo, Eisai, Kowa, Mitsubishi Tanabe, Otsuka, Shionogi and

Deal Watch March 2017

Resarci out-licensed ACAT-1 to Xynomic, as detailed above, and Daiichi Sankyo paid $4m upfront, committed $8m in research funding and further research, development and commercialisation milestone payments for the ... 20. Heptares/ Sosei Group. Daiichi

Hookipa Biotech appoints new global head of research and development

Hookipa Biotech appoints new global head of research and development. Dr Igor Matushansky joins the firm from Daiichi Sankyo. ... Previously global head of translational development for oncology at Daiichi Sankyo, Matushansky has experience in early

Xarelto beats aspirin for recurrent blood clots

rival NOAC Eliquis (apixaban) from Pfizer and Bristol-Myers Squibb (BMS) with 42.5%, well ahead of third place Pradaxa (dabigatran) from Boehringer Ingelheim and Daiichi Sankyo's new entrant Savaysa

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 5)

Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA

Japan revenue 2014
1: Takeda
2: Otsuka
3: Meiji
4: Astellas
5: Daiichi Sankyo
6: Teijin
7: Eisai
8: Chugai
9: Mitsubishi Tanabe
10: Kyowa Hakko Kirin
11: Taisho
12: Shionogi
13: Hisamitsu
14: Santen
15: Ono
16: Kyorin
17: Nichi-Iko
18: Mochida
19: Sawai
20: Kaken
21: Kissei
22: Zeria
23: Towa
24: Torii
25: Daito

Immunology revenue 2014
1: AbbVie
2: Johnson & Johnson
3: Pfizer
4: Amgen
5: Merck & Co.
6: Astellas
7: Roche
8: Novartis
9: Bristol-Myers Squibb
10: Mitsubishi Tanabe
11: UCB
12: Hisamitsu
13: Daiichi Sankyo
14: Takeda

Cardiovascular revenue 2014
1: AstraZeneca
2: Sanofi
3: Merck & Co.
4: Daiichi Sankyo
5: Pfizer
6: Novartis
7: Bayer
8: Takeda
9: Boehringer Ingelheim
10: Astellas
11: Actelion
12: Johnson & Johnson
13: Shionogi
14: United Therapeutics
15: Bristol-Myers Squibb
16: Gilead Sciences
17: Otsuka
18: Roche
19: Lilly
20: The Medicines Company

Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Principal Medical Writer: Great salary and benefits

Brand Communications Manager: A competitive salary plus bonus

Senior Medical Writer, Healthcare Advertising, Home Counties: Competitive

Senior Account Manager – Healthcare PR: Salary TBC

Medical Writer – Creative Healthcare Advertising – London: Salary TBC

Account Manager, Healthcare PR, Global and UK: £33, 000 – £40, 000

Account Director - Healthcare Advertising - London: £50000 - £68000

Scientific Director: £70, 000 - £85, 000

Senior Account Director, Medical Communications, London: Competitive

Director – Healthcare PR/ Policy: Salary TBC

Senior Corporate Communications Manager: Competitive Salary

6-12 MONTH FREELANCE OPPORTUNITY - ACCOUNT DIRECTOR or SENIOR AC...: SUPERB DAY RATE AVAILABLE

FREELANCE *Client Service/ Project Manager*: Competitive Salary

Senior Medical Writer: Great salary and benefits

Account Manager, Healthcare Advertising (Agency or Pharma backgr...: Competitive

Account Manager, Medical Communications: £30, 000-£40, 000

*Design Manager*: Competitive Salary

Consultant, Pricing and Market Access, Home based role, UK: Competitive

*Multi-Channel Creative Designer*: Competitive Salary

Account Director or Senior Account Director, Healthcare Advertis...: £55, 000 - £65, 000 benefits

Senior Director, Healthcare PR, Home Counties: Competitive

Principal Medical Writer to Project Director? Med Comms: Salary TBC

Account Director - Med Comms: Great salary and benefits

Head of Marketing Insulin: Competitive Salary

The new pharma marketing playbook: Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity: Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing: Achieve real health behaviour change by including these elements in your pharmaceutical marketing....